Search Results
Found 1 results
510(k) Data Aggregation
(91 days)
The Bard® LUMINEXX™ 3 Biliary Stent and Delivery System is indicated for use in the treatment of biliary strictures resulting from malignant neoplasms.
The Bard® LUMINEXX™ 3 Biliary Stent and Delivery System is a stenting device, designed to maintain the patency of biliary ducts obstructed by malignant neoplasms. The device includes a self-expanding Bard® LUMINEXX™ 3 biliary stent pre-loaded on a flexible delivery system. Highly radiopaque markers on the ends of the stent facilitate stent placement. The Bard® LUMINEXX™ 3 Biliary Stent and Delivery System is available in several diameters and lengths.
The provided text does not contain information about acceptance criteria, device performance metrics, or a study demonstrating that the device meets such criteria. The document is a 510(k) premarket notification letter for the Bard® LUMINEXX™ 3 Biliary Stent and Delivery System, which focuses on establishing substantial equivalence to a predicate device.
Therefore, I cannot provide the requested information. The text does not include details on:
- A table of acceptance criteria and reported device performance.
- Sample size for the test set or data provenance.
- Number of experts used to establish ground truth or their qualifications.
- Adjudication method for the test set.
- A multi-reader multi-case (MRMC) comparative effectiveness study or its effect size.
- Standalone algorithm performance.
- Type of ground truth used.
- Sample size for the training set.
- How ground truth for the training set was established.
Ask a specific question about this device
Page 1 of 1